30
CARDIOVASCULAR
hamburger
Xience Family

Introducing XIENCE Skypoint™ Stent 4.5 MM and 5.0 MM Sizes, to Treat Large Vessels

XIENCE Skypoint™ Stent delivers the broadest expansion range in the latest generation XIENCE™ Stent, the DES that consistently delivers successful outcomes—not only in the cath-lab, but far beyond. Now available with 4.5 mm and 5.0 mm sizes.2

Treat a Wide Range of Large Vessel Lesions4

XIENCE Stent Supports Accurate Stent Placement5

Indicated for Patients with Left Main Coronary Artery Lesions
 

Xience Skypoint
Skypoint Stent Diagram


Treat a Wide Range of Large Vessel Lesions With XIENCE Skypoint™ Stents4

New Sizes

XIENCE Skypoint™ Stent offers a range of stent lengths from 12 mm to 33 mm to help treat a wide range of patients.4


12 mm
to
33 mm
Stent Sizes
Stent Diameter Stent Length
12 mm 15 mm 18 mm 23 mm 28 mm 33 mm Maximum Expansion
4.5 mm 5.75 mm
5.0 mm 5.75 mm


XIENCE Skypoint™ Stent Supports Accurate Stent Placement Through Precise Stent and Marker Placement5

Precise Scaffolding

 

 

Accurate mid-marker placement enables precise scaffolding and reduces the likelihood of geographic miss to support optimal patient outcomes.5,6

Scaffolding comparison to Synergy and Resolute Onyx

XIENCE Skypoint™ Stent has Significantly Better Longitudinal Strength Than Other DES in Large Vessels7

Longitudinal strength supports better scaffolding in large coronary vessels. Less stent deformation delivers better patient outcomes.8
 

Skypoint Stent Deformation
XIENCE Skypoint™ Stent Shows Significantly Less Stent Deformation Than
Synergy and Resolute Onyx – 5.0 mm Stents

*Denotes significantly different when compared with XIENCE Skypoint™ Stent.

XIENCE™ Stent Shows Improvements in Measures of Quality of Life (QoL) in Patients With Left Main Lesions at 3 Years9






PCI With XIENCE™ Stent in patients with left main lesions showed sustained improvements in QoL out to 3 years9

SAQ - Quality of Life
SAQ - Quality of Life*

*Quality of life is a subscale of the Seattle Angina Questionnaire (SAQ). Scores for each subscale range from 0 to 100 with higher scores representing better health status. Comparison is made Vs baseline.
** Denotes statistically significant difference from baseline.




 

81% rate
Angina Free Incidences
Frequency of Angina-Free Incidences as Measured by SAQ – AF*

* Frequency of Angina is a subscale of the Seattle Angina Questionnaire (SAQ). Comparison is made vs baseline.
** Denotes statistically significant difference from baseline.

XIENCE™ Stent shows significantly lower definite stent thrombosis rates than Synergy in patients with left main lesions at 2 years10

ST Patients
Definite Stent Thrombosis

DAPT Indications

References

  1. XIENCE Skypoint™ Stent Instructions For Use (IFU). Refer to IFU for additional information.
  2. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information. Zanchin, C. et al. J Am Coll Cardiol Intv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Kufner S, et al. Circulation. 2019:139(3):325-333.
  3. Data on file at Abbott.
  4. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information.
  5. Data on file at Abbott. XIENCE Skypoint™ Stent vs. Synergy and Resolute Onyx – 5.0 x 18 or 20 mm stents tested.
  6. Costa M, et al. Am J Cardiol. 2008;101:1704-1711; Sudhir, K., et al. ISRN Cardiology. 2013:1-8.
  7. Data on file at Abbott. XIENCE Skypoint™ Stent – 5.0 x 33 mm, n=5. Synergy 5.0 x 32 mm, n=2. Resolute Onyx – 5.0 x 33 mm , n=5. *Denotes significantly different when compared with XIENCE Skypoint™ Stent. Longitudinal stent compression test was done using 50 gf load.
  8. Shand J, et al. Interv Cardiol. 2012;4:325-335.
  9. Baron S, et al. J Am Coll Cardiol. 2017;70:3113-3122.
  10. Van Geuns R, et al. IDEAL-LM. TCT 2019
Request a Rep

MAT-2208522 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.